Former Pfizer VP Michael Yeadon maintains that since the infection fatality ratio of COVID-19 has not been high, the vaccines should not have been mandated.
Moreover, he heavily blasted the corporate media mantras that designate these as safe, effective, and necessary to end the CCP (Chinese Communist Party) virus pandemic.
Yeadon is a big pharma veteran with 32 years in the industry. He worked as the head of allergy and respiratory research at Pfizer from 1995 to 2011 and is the former founder and CEO of Ziarco, a biotech company acquired by Novartis. Furthermore, he has a doctorate in respiratory pharmacology and holds a Double First Class Honors degree in biochemistry and toxicology.
A shocking 1,223 deaths and 42,086 adverse events were reported to Pfizer from the first day of the Pfizer-BioNTech vaccine rollout on Dec. 1, 2020, to Feb. 28, 2021.
“The worst flu season over the last decade is worse than [the threat] posed by this new virus,” Yeadon told The Epoch Times via email.
“And what do we do in response to seasonal influenza? Well, nothing really, beyond offering—and not mandating—vaccines which aren’t much use.”
Of important note is that the exact number of fatalities in China, where the virus originated, has been suppressed by the communist regime and could be 366 times the official figure.
Yeadon said that being sure the vaccines would cause no harm in the long run should have been imperative.
“It was never appropriate to attempt to ‘end the pandemic’ with a novel technology vaccine. In a public health mass intervention, safety is the top priority, more so even than effectiveness, because so many people will receive it,” Yeadon states in a document he sent to The Epoch Times.
“It’s simply not possible to obtain data demonstrating adequate longitudinal safety in the time period any pandemic can last. Those who pushed this line of argument and enabled the gene-based agents to be injected needlessly into billions of innocent people are guilty of crimes against humanity.”
Read Full Article on TheEpochTimes.com
